Clinical Trial

EOSS-ATTR Study (eHealth Based Operative Support System in ATTR-CM)

Study acronym: eOSS-ATTR
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated October 23, 2024 (before its estimated March 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Unicenter, proof-of-concept, prospective, randomised, controlled, open-label and blinded end-point adjudication trial to assess the effect on patient-reported outcomes measures (PROMs), patient-reported experience measures (PREMs) and clinical events of a mHealth-based comprehensive management program for patients with chronic heart failure (HF) due to transthyretin-associated amyloidosis (ATTR)-cardiomyopathy (CM) by means of remote daily telemonitoring of signs and symptoms and remote structured follow-up using videoconference.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06499064
Lead Sponsor Hospital Universitari de Bellvitge
Collaborators: Institut d'Investigació Biomèdica de Bellvitge
Conditions Heart Failure, Amyloid Cardiomyopathy, ATTR Amyloidosis Wild Type, ATTR Gene Mutation
Enrollment 50 participants
Start Date 2024-12-01
Primary Completion 2026-03-15 (estimated)
Study Completion 2026-03-15 (estimated)
Updated on ClinicalTrials.gov 2024-10-23